Your browser doesn't support javascript.
loading
Assessment of biosimilarity under native and heat-stressed conditions: rituximab, bevacizumab, and trastuzumab originators and biosimilars.
Kang, Jukyung; Halseth, Troy; Vallejo, Daniel; Najafabadi, Zeynab Izadi; Sen, K Ilker; Ford, Michael; Ruotolo, Brandon T; Schwendeman, Anna.
Afiliação
  • Kang J; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA.
  • Halseth T; Biointerfaces Institute, University of Michigan, 2800 Plymouth Road, Ann Arbor, MI, 48109, USA.
  • Vallejo D; Biointerfaces Institute, University of Michigan, 2800 Plymouth Road, Ann Arbor, MI, 48109, USA.
  • Najafabadi ZI; Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
  • Sen KI; Department of Chemistry, University of Michigan, Ann Arbor, MI, USA.
  • Ford M; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA.
  • Ruotolo BT; Protein Metrics Inc., San Carlos, CA, USA.
  • Schwendeman A; MS Bioworks, Ann Arbor, MI, USA.
Anal Bioanal Chem ; 412(3): 763-775, 2020 Jan.
Article em En | MEDLINE | ID: mdl-31853605

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Bevacizumab / Trastuzumab / Rituximab / Temperatura Alta Idioma: En Revista: Anal Bioanal Chem Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Bevacizumab / Trastuzumab / Rituximab / Temperatura Alta Idioma: En Revista: Anal Bioanal Chem Ano de publicação: 2020 Tipo de documento: Article